All articles by Phillip Broadwith – Page 3
-
BusinessUS judge overturns Purdue’s opioid bankruptcy settlement
Ruling says bankruptcy court did not have authority to grant Sackler family protection from future litigation
-
OpinionWhen regulatory cooperation goes too far, we all lose
Were FDA staff unduly influenced by Biogen in approving Alzheimer’s antibody?
-
BusinessFatal incident in German chemicals park
One dead and five injured by caustic soda being used for cleaning work
-
BusinessDiversity is at the heart of innovation
To challenge conventions we need to include people who think differently
-
OpinionA clouded view of industry emissions
Standards and auditing are sorely needed if emissions targets are to be upheld
-
BusinessPfizer sues former employee for alleged trade secret theft
Chun Xiao Li downloaded thousands of confidential documents before resigning
-
BusinessChemical plant fire in Pakistan kills at least 17 workers
Blocked windows and exits hampered rescue efforts
-
BusinessMassive fire at UK polyurethanes plant
One worker remains missing a week after Leamington Spa incident
-
BusinessDeadly explosion and fire at chemicals park in Germany
At least 2 dead and 31 injured when an explosion led to a solvent tank fire in Leverkusen
-
BusinessBMS and Eisai agree antibody-drug conjugate commercialisation deal
Companies will jointly develop cancer treatment, with BMS paying up to $3 billion for shared rights
-
BusinessMorphosys agrees to buy cancer epigenetics specialist Constellation
$1.7bn deal will be funded by selling rights to royalties on existing drugs
-
BusinessFatal explosion at US paint and polymers plant
One dead and nine others injured as building partially collapsed after explosion and fire
-
-
Business4 dead in UK sewage treatment works explosion
One person injured as biosolids silo explodes at Avonmouth
-
-
OpinionA promising peep at Covid-19 vaccine efficacy
Pfizer–BioNTech’s will need to be one of many if we are to overcome the pandemic
-
BusinessInnovation is a fragile transition state
Brexit and Covid-19 will likely stifle interactions, but could also stimulate new ones
-
OpinionImproving executive diversity is a priority
A few hiring decisions could make a big difference at leadership level
-
PodcastSofosbuvir
The hepatitis C drug that made waves when first launched – quicker to work and with fewer side effects than existing drugs, but it came with a hefty price tag
-
OpinionJumping the vaccine queue
Deals between companies and rich governments offset manufacturing risks, but must not compromise supplies to those in need